Atlantic Coastal Acquisition Corp. II - Crunchbase Company Profile & Funding

Q: How much funding has Atlantic Coastal Acquisition Corp. II raised to date?

Atlantic Coastal Acquisition Corp. II has raised obfuscated.

Overview

Atlantic Coastal Acquisition Corp. II

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Atlantic Coastal Acquisition Corp. II

CB Rank

72650

Atlantic Coastal Acquisition Corp. II is a blank check company.

Founded

obfuscation

Public

Post-IPO Equity

New York, New York, United States

1-10

abpro.co

Asset Management

Biotechnology

Finance

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Eugene Cha: CEO & CO-FOUNDER
John Xu: SVP OF STRATEGIC ALLIANCES

Details

Legal Name

Abpro Corporation

Operating Status

Active

Stock Symbol

NASDAQ:ABP

Company Type

For Profit

Founders

Eugene Cha, Ian Chan

About the Company

Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins

and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds.

Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.

Phone Number

(800) 396-5890

Contact Email

info@abpro-labs.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Next-Generation Antibody Therapies

Abpro develops antibody therapeutics using DiversImmune® and MultiMab™ platforms to create bi- and multi-specific antibodies for various diseases.

DiversImmune® Antibody Discovery Platform

This platform generates high affinity and high specificity antibodies against difficult therapeutic targets.

Research & Development

Atlantic Coastal Acquisition Corp. II is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	1	obfuscated obfuscation	Celltrion	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Celltrion	Yes	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	—
Celltrion	Yes	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	—
Celltrion	Yes	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	—
Celltrion	Yes	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	—
Celltrion	Yes	Post-IPO Equity - Atlantic Coastal Acquisition Corp. II	—